Young‐Min Lim

2.4k total citations
100 papers, 1.7k citations indexed

About

Young‐Min Lim is a scholar working on Neurology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Young‐Min Lim has authored 100 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Neurology, 27 papers in Pathology and Forensic Medicine and 21 papers in Molecular Biology. Recurrent topics in Young‐Min Lim's work include Peripheral Neuropathies and Disorders (23 papers), Multiple Sclerosis Research Studies (22 papers) and CNS Lymphoma Diagnosis and Treatment (7 papers). Young‐Min Lim is often cited by papers focused on Peripheral Neuropathies and Disorders (23 papers), Multiple Sclerosis Research Studies (22 papers) and CNS Lymphoma Diagnosis and Treatment (7 papers). Young‐Min Lim collaborates with scholars based in South Korea, United States and Australia. Young‐Min Lim's co-authors include Kwang‐Kuk Kim, Eun‐Jae Lee, Hyunjin Kim, Namhyun Chung, Eun‐Kyung Ahn, Kweon-Haeng Lee, Ki Heon Kim, Seoyoung Park, Yong Kwon Lee and Joo‐Yong Lee and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Neurology.

In The Last Decade

Young‐Min Lim

95 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Young‐Min Lim South Korea 24 591 404 368 198 174 100 1.7k
Radhika Iyer United States 20 367 0.6× 881 2.2× 122 0.3× 57 0.3× 143 0.8× 39 1.7k
Maria Caffo Italy 21 344 0.6× 309 0.8× 72 0.2× 51 0.3× 138 0.8× 98 1.3k
Ekaterini Tsilou United States 22 348 0.6× 948 2.3× 226 0.6× 41 0.2× 163 0.9× 36 2.2k
Grazia M.S. Mancini Netherlands 28 157 0.3× 1.2k 2.9× 183 0.5× 21 0.1× 243 1.4× 79 2.7k
James Laredo United States 25 369 0.6× 515 1.3× 107 0.3× 26 0.1× 95 0.5× 42 1.9k
Xiaojian Cao China 28 78 0.1× 614 1.5× 568 1.5× 23 0.1× 233 1.3× 101 2.1k
Akira Teramoto Japan 31 832 1.4× 961 2.4× 211 0.6× 23 0.1× 229 1.3× 239 3.7k
Robert Lawson United States 15 804 1.4× 343 0.8× 32 0.1× 28 0.1× 145 0.8× 32 1.6k
Yue Wang China 31 86 0.1× 1.8k 4.4× 107 0.3× 51 0.3× 269 1.5× 148 3.2k
Masato Yano Japan 27 301 0.5× 1.5k 3.6× 58 0.2× 31 0.2× 153 0.9× 69 2.6k

Countries citing papers authored by Young‐Min Lim

Since Specialization
Citations

This map shows the geographic impact of Young‐Min Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Young‐Min Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Young‐Min Lim more than expected).

Fields of papers citing papers by Young‐Min Lim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Young‐Min Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Young‐Min Lim. The network helps show where Young‐Min Lim may publish in the future.

Co-authorship network of co-authors of Young‐Min Lim

This figure shows the co-authorship network connecting the top 25 collaborators of Young‐Min Lim. A scholar is included among the top collaborators of Young‐Min Lim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Young‐Min Lim. Young‐Min Lim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lim, Young‐Min, et al.. (2025). Oxaliplatin-Induced Acute Peripheral Nerve Hyperexcitability. Journal of Clinical Neurology. 21(3). 235–235.
2.
Nishino, Ichizo, Shigeaki Suzuki, Bum Chun Suh, et al.. (2025). Profiling of Anti-Signal-Recognition Particle Antibodies and Clinical Characteristics in South Korean Patients With Immune-Mediated Necrotizing Myopathy. Journal of Clinical Neurology. 21(1). 31–31. 1 indexed citations
3.
Kim, Ki Hoon, Ju‐Hong Min, Seung Woo Kim, et al.. (2024). Immunosuppressive therapy in elderly patients with neuromyelitis optica spectrum disorder: a retrospective multicentre study. Journal of Neurology Neurosurgery & Psychiatry. 95(12). 1168–1175. 4 indexed citations
4.
Park, Jong-Eun, Wangyong Shin, Hyunji Kim, et al.. (2023). Distinct features of B cell receptors in neuromyelitis optica spectrum disorder among CNS inflammatory demyelinating diseases. Journal of Neuroinflammation. 20(1). 225–225. 3 indexed citations
5.
Jang, Yoon Ok, Hee‐Sung Ahn, Wangyong Shin, et al.. (2023). Magnetic transferrin nanoparticles (MTNs) assay as a novel isolation approach for exosomal biomarkers in neurological diseases. Biomaterials Research. 27(1). 12–12. 23 indexed citations
6.
Huh, So‐Young, Su‐Hyun Kim, Ki Hoon Kim, et al.. (2022). Safety and Temporal Pattern of the Lymphocyte Count During Fingolimod Therapy in Patients With Multiple Sclerosis: Real-World Korean Experience. Journal of Clinical Neurology. 18(6). 663–663. 3 indexed citations
7.
Paik, Wooyul, Young‐Chul Choi, Young‐Min Lim, et al.. (2021). Clinical Features and Brain MRI Findings in Korean Patients with AGel Amyloidosis. Yonsei Medical Journal. 62(5). 431–431. 3 indexed citations
8.
Lee, Hye Lim, Jin‐Woo Park, Jin Myoung Seok, et al.. (2021). Serum Peptide Immunoglobulin G Autoantibody Response in Patients with Different Central Nervous System Inflammatory Demyelinating Disorders. Diagnostics. 11(8). 1339–1339. 4 indexed citations
9.
Lim, Young‐Min, et al.. (2020). Beneficial effects of intravenous immunoglobulin as an add-on therapy to azathioprine for NMO-IgG-seropositive neuromyelitis optica spectrum disorders. Multiple Sclerosis and Related Disorders. 42. 102109–102109. 8 indexed citations
10.
Kim, Hyunjin, et al.. (2020). Anti-CASPR2-Antibody-Positive Isaacs' Syndrome Presenting with Myokymia, Neuropathic Pain, and Hyperhidrosis. Journal of Clinical Neurology. 16(4). 699–699. 4 indexed citations
11.
Lee, Eun‐Jae, Young‐Min Lim, Hyunjin Kim, et al.. (2020). Clinical implication of serum biomarkers and patient age in inflammatory demyelinating diseases. Annals of Clinical and Translational Neurology. 7(6). 992–1001. 31 indexed citations
12.
Kim, Hyunjin, et al.. (2019). Efficacy and safety of alemtuzumab in Korean multiple sclerosis patients. Multiple Sclerosis and Related Disorders. 30. 247–251. 6 indexed citations
13.
Kim, Jee‐Eun, Jin Myoung Seok, Suk-Won Ahn, et al.. (2019). Basic concepts of needle electromyography. 21(1). 7–7. 3 indexed citations
14.
Chung, Sun Ju, Kwang‐Kuk Kim, Dong‐Wha Kang, et al.. (2014). Emotional Disturbance in CADASIL: Its Impact on Quality of Life and Caregiver Burden. Cerebrovascular Diseases. 37(3). 188–194. 28 indexed citations
15.
Lu, Shanshan, et al.. (2013). Utility of Proton MR Spectroscopy for Differentiating Typical and Atypical Primary Central Nervous System Lymphomas from Tumefactive Demyelinating Lesions. American Journal of Neuroradiology. 35(2). 270–277. 41 indexed citations
16.
Lim, Young‐Min, et al.. (2012). Peripheral Neuropathy Associated with Human Immunodeficiency Virus Infection. 14(1). 29–35.
17.
Lim, Young‐Min, et al.. (2012). Small fiber function in drug naïve patients with idiopathic restless legs syndrome. Journal of Clinical Neuroscience. 19(5). 702–705. 14 indexed citations
18.
Yun, Young-Pil, Jin‐Deok Joo, Joo‐Yong Lee, et al.. (2004). Induction of nuclear factor-κB activation through TAK1 and NIK by diesel exhaust particles in L2 cell lines. Toxicology Letters. 155(2). 337–342. 10 indexed citations
19.
Lee, Joo‐Yong, et al.. (2003). Silica induces nuclear factor-κB activation through TAK1 and NIK in Rat2 cell line. Toxicology Letters. 143(3). 323–330. 10 indexed citations
20.
Kim, Eun Ran, Young‐Min Lim, Jeong Ok Hah, et al.. (1995). . International Journal of Hematology. 62. 1–1. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026